Active specific immunotherapy: mechanisms of action and clinical applications in bioregenerative and anti-aging medicine, autoimmune conditions and cancers

Autologous Active Specific Immunotherapy (AASI) is a type of immunotherapy that targets complementary autoantibodies which suppress the specific immune response using anti-idiotypic antibodies. AASI entails removing cells (dendritic cells) from patient's blood and subjecting them in lab setting to particular tumour antigen (proteins detected on surface cancer cells). personalized treatment approach has been used treat various types cancer, including melanoma, osteosarcoma breast cancer. Clinical trials have shown promising results, with some patients experiencing complete remission or long-term disease control. Although potential as treatment, further research needed optimize its effectiveness safety. complex expensive therapy, use currently limited specialized centres.